424 related articles for article (PubMed ID: 31660033)
1. Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines.
Ruan J; Ping CY; Sun S; Cheng X; Han PY; Zhang YG; Sun DX
World J Gastroenterol; 2019 Oct; 25(39):5961-5972. PubMed ID: 31660033
[TBL] [Abstract][Full Text] [Related]
2. Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.
Wang Z; Wu L; Cheng X; Liu S; Li B; Li H; Kang F; Wang J; Xia H; Ping C; Nassal M; Sun D
PLoS One; 2013; 8(4):e60306. PubMed ID: 23589756
[TBL] [Abstract][Full Text] [Related]
3. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
4. [Tetracycline-inducible replications of wild-type and an adefovir-dipivoxil-resistant hepatitis B virus in human liver cells].
Wang JH; Wang XY; Fei R; Zhang HY; Wei L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):351-6. PubMed ID: 27029368
[TBL] [Abstract][Full Text] [Related]
5. [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene].
Liu JX; Sun DX; Cao ZC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):316-8. PubMed ID: 20108785
[TBL] [Abstract][Full Text] [Related]
6. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of a HBV vector plasmid expressing A3C on HBV replication].
Li D; Wang YM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2044-7, 2050. PubMed ID: 19861262
[TBL] [Abstract][Full Text] [Related]
8. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
9. [Approach to transforming hepatitis B virus as a gene therapeutic vector].
Han JQ; Hu DR; Hu XL; Sun DX; Fan GR; Liu CY; Wu YP
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):344-6. PubMed ID: 12837212
[TBL] [Abstract][Full Text] [Related]
10. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
11. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
[TBL] [Abstract][Full Text] [Related]
12. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
Kumar M; Follenzi A; Garforth S; Gupta S
Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
[TBL] [Abstract][Full Text] [Related]
13. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
[TBL] [Abstract][Full Text] [Related]
14. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector.
Lucifora J; Durantel D; Belloni L; Barraud L; Villet S; Vincent IE; Margeridon-Thermet S; Hantz O; Kay A; Levrero M; Zoulim F
J Gen Virol; 2008 Aug; 89(Pt 8):1819-1828. PubMed ID: 18632952
[TBL] [Abstract][Full Text] [Related]
15. Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines.
Wu Y; Zhang TY; Fang LL; Chen ZX; Song LW; Cao JL; Yang L; Yuan Q; Xia NS
J Virol Methods; 2016 Aug; 234():96-100. PubMed ID: 27091097
[TBL] [Abstract][Full Text] [Related]
16. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease.
Sun C; Gardner CL; Watson AM; Ryman KD; Klimstra WB
J Virol; 2014 Feb; 88(4):2035-46. PubMed ID: 24307590
[TBL] [Abstract][Full Text] [Related]
17. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.
Hong R; Bai W; Zhai J; Liu W; Li X; Zhang J; Cui X; Zhao X; Ye X; Deng Q; Tiollais P; Wen Y; Liu J; Xie Y
J Virol; 2013 Jun; 87(12):6615-24. PubMed ID: 23552416
[TBL] [Abstract][Full Text] [Related]
19. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
Fu L; Cheng YC
Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
